Health Condition 1: null- Patients of infantile nystagmus syndrome will be included.
Conditions
Interventions
Intervention1: brinzolamide eye drop: To evaluate the effect of topical brinzolamide v/s placebo on visual function and wave form in patient of infantile nystagmus syndrome
Control Intervention1: plac
Sponsors
Pharmacology department RPC
Eligibility
Inclusion criteria
Inclusion criteria: 1.Informed consent from self or guardian(in case of minor) 2.Subjects will have INS diagnosed by clinical evaluation and eye movement recordings 3.will be >=10 years of age 4.will able to make the required study visits.
Exclusion criteria
Exclusion criteria: 1.Current or within the last 12 months use of medications for nystagmus, history of any ocular surgery. 2.Any systemic diseases requiring medication known to affect the ocular motor system 3.Behavioural or neurological disorders which would interfere with the study 4.Pregnancy,nursing or planning of a pregnancy and 5.Known allergy to brinzolamide 6.Participation in any study involving an investigational new drug within the past year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in visual function and wave form in patients of infantile nystagmus syndromeTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr Bhupendra Yadav
Dr.Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences
Outcome results
None listed